AMPH logo

Amphastar Pharmaceuticals (AMPH) Depreciation And Amortization

Annual D&A

$41.78 M
+$13.50 M+47.75%

31 December 2023

1-Year Change

+47.75%
AMPH annual depreciation & amortization is up +47.75% year-on-year

3-Year Change

+65.91%
AMPH annual depreciation & amortization is up +65.91% over the past 3 years

All-time High

$41.78 M
AMPH annual depreciation & amortization is currently at an all-time high

Sector Rank

84%
AMPH annual depreciation & amortization is higher than 84% of companies in Healthcare sector
Annual Total Expenses$447.41 M
AMPH annual total expenses is $447.41 million
Annual Operating Expenses$154.13 M
AMPH annual total operating expenses is $154.13 million
Annual Revenue$644.39 M
AMPH annual revenue is $644.39 million
Annual Net Income$137.54 M
AMPH annual net profit is $137.54 million

AMPH Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$14.43 M
+$288.00 K+2.04%

30 September 2024

1-Year Change

+6.35%
AMPH quarterly depreciation & amortization is up +6.35% year-on-year

3-Year Change

+121.71%
AMPH quarterly depreciation & amortization is up +121.71% over the past 3 years

All-time High

$14.43 M
AMPH quarterly depreciation & amortization is currently at an all-time high

Sector Rank

85.36%
AMPH quarterly depreciation & amortization is higher than 85.36% of companies in Healthcare sector
Quarterly Total Expenses$134.17 M
AMPH quarterly total expenses is $134.17 million
Quarterly Operating Expenses$44.89 M
AMPH quarterly total operating expenses is $44.89 million
Quarterly Revenue$191.21 M
AMPH quarterly revenue is $191.21 million
Quarterly Net Income$40.43 M
AMPH quarterly net profit is $40.43 million

AMPH Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$56.33 M
+$862.00 K+1.55%

30 September 2024

1-Year Change

+59.51%
AMPH TTM depreciation & amortization is up +59.51% year-on-year

3-Year Change

+108.85%
AMPH TTM depreciation & amortization is up +108.85% over the past 3 years

All-time High

$56.33 M
AMPH TTM depreciation & amortization is currently at an all-time high

Sector Rank

85.36%
AMPH TTM depreciation & amortization is higher than 85.36% of companies in Healthcare sector
Annual Total Expenses$447.41 M
AMPH annual total expenses is $447.41 million
Annual Operating Expenses$154.13 M
AMPH annual total operating expenses is $154.13 million
TTM Revenue$723.55 M
AMPH TTM revenue is $723.55 million
TTM Net Income$157.72 M
AMPH TTM net profit is $157.72 million

AMPH TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AMPH Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+47.8%+6.3%+59.5%
3 y3 years+65.9%+121.7%+108.8%
5 y5 years+152.9%+174.1%+183.5%

AMPH Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+65.9%at high+127.9%at high+112.8%
5 y5 yearsat high+152.9%at high+174.1%at high+183.5%
alltimeall timeat high+274.7%at high+374.9%at high+1753.6%

Amphastar Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$14.43 M(+2.0%)
$56.33 M(+1.6%)
June 2024
-
$14.14 M(+1.3%)
$55.47 M(+14.7%)
Mar 2024
-
$13.96 M(+1.3%)
$48.34 M(+15.7%)
Dec 2023
$41.78 M(+47.8%)
$13.79 M(+1.6%)
$41.78 M(+18.3%)
Sept 2023
-
$13.57 M(+93.3%)
$35.31 M(+21.5%)
June 2023
-
$7.02 M(-5.1%)
$29.07 M(+0.7%)
Mar 2023
-
$7.40 M(+1.0%)
$28.88 M(+2.1%)
Dec 2022
$28.27 M(+6.6%)
$7.33 M(+0.0%)
$28.27 M(+3.6%)
Sept 2022
-
$7.33 M(+7.3%)
$27.28 M(+3.1%)
June 2022
-
$6.83 M(+0.5%)
$26.47 M(-0.1%)
Mar 2022
-
$6.79 M(+7.3%)
$26.50 M(-0.1%)
Dec 2021
$26.53 M(+5.4%)
$6.33 M(-2.7%)
$26.53 M(-1.6%)
Sept 2021
-
$6.51 M(-5.2%)
$26.97 M(-0.6%)
June 2021
-
$6.87 M(+0.6%)
$27.13 M(+3.6%)
Mar 2021
-
$6.83 M(+0.8%)
$26.18 M(+4.0%)
Dec 2020
$25.18 M(+19.2%)
$6.77 M(+1.5%)
$25.18 M(+4.7%)
Sept 2020
-
$6.67 M(+12.7%)
$24.04 M(+6.2%)
June 2020
-
$5.92 M(+1.6%)
$22.63 M(+3.8%)
Mar 2020
-
$5.82 M(+3.4%)
$21.81 M(+3.3%)
Dec 2019
$21.12 M(+27.9%)
$5.63 M(+6.9%)
$21.12 M(+6.3%)
Sept 2019
-
$5.26 M(+3.3%)
$19.87 M(+5.8%)
June 2019
-
$5.09 M(-0.7%)
$18.78 M(+5.2%)
Mar 2019
-
$5.13 M(+17.2%)
$17.86 M(+8.1%)
Dec 2018
$16.52 M
$4.38 M(+5.0%)
$16.52 M(+2.3%)
DateAnnualQuarterlyTTM
Sept 2018
-
$4.17 M(-0.1%)
$16.14 M(+0.2%)
June 2018
-
$4.17 M(+10.2%)
$16.11 M(+2.1%)
Mar 2018
-
$3.79 M(-5.3%)
$15.78 M(-0.2%)
Dec 2017
$15.81 M(+7.7%)
$4.00 M(-3.4%)
$15.81 M(+0.5%)
Sept 2017
-
$4.15 M(+8.0%)
$15.72 M(+2.8%)
June 2017
-
$3.84 M(+0.5%)
$15.29 M(+1.5%)
Mar 2017
-
$3.82 M(-2.5%)
$15.07 M(+2.7%)
Dec 2016
$14.68 M(+10.8%)
$3.92 M(+5.5%)
$14.68 M(+4.6%)
Sept 2016
-
$3.71 M(+2.7%)
$14.04 M(+2.6%)
June 2016
-
$3.62 M(+5.5%)
$13.69 M(+1.9%)
Mar 2016
-
$3.43 M(+4.6%)
$13.43 M(+1.3%)
Dec 2015
$13.25 M(-8.3%)
$3.28 M(-2.5%)
$13.25 M(-3.6%)
Sept 2015
-
$3.36 M(+0.1%)
$13.75 M(-2.3%)
June 2015
-
$3.36 M(+3.3%)
$14.07 M(-1.5%)
Mar 2015
-
$3.25 M(-13.9%)
$14.29 M(-1.1%)
Dec 2014
$14.45 M(+10.5%)
$3.78 M(+2.6%)
$14.45 M(+2.2%)
Sept 2014
-
$3.68 M(+2.9%)
$14.13 M(+3.0%)
June 2014
-
$3.58 M(+4.7%)
$13.72 M(+2.0%)
Mar 2014
-
$3.42 M(-1.3%)
$13.45 M(+2.9%)
Dec 2013
$13.08 M(+13.8%)
$3.46 M(+5.8%)
$13.08 M(+36.0%)
Sept 2013
-
$3.27 M(-1.1%)
$9.62 M(+51.5%)
June 2013
-
$3.31 M(+8.9%)
$6.35 M(+108.9%)
Mar 2013
-
$3.04 M
$3.04 M
Dec 2012
$11.50 M(+3.1%)
-
-
Dec 2011
$11.15 M
-
-

FAQ

  • What is Amphastar Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual D&A year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly D&A year-on-year change?
  • What is Amphastar Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals TTM D&A year-on-year change?

What is Amphastar Pharmaceuticals annual depreciation & amortization?

The current annual D&A of AMPH is $41.78 M

What is the all time high annual D&A for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual depreciation & amortization is $41.78 M

What is Amphastar Pharmaceuticals annual D&A year-on-year change?

Over the past year, AMPH annual depreciation & amortization has changed by +$13.50 M (+47.75%)

What is Amphastar Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of AMPH is $14.43 M

What is the all time high quarterly D&A for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly depreciation & amortization is $14.43 M

What is Amphastar Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, AMPH quarterly depreciation & amortization has changed by +$862.00 K (+6.35%)

What is Amphastar Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of AMPH is $56.33 M

What is the all time high TTM D&A for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high TTM depreciation & amortization is $56.33 M

What is Amphastar Pharmaceuticals TTM D&A year-on-year change?

Over the past year, AMPH TTM depreciation & amortization has changed by +$21.02 M (+59.51%)